Please check your internet connection and try again.
# Magnesium Sulfate
## Overview
Magnesium sulfate is an essential mineral and electrolyte. It acts as a cofactor for numerous enzymatic reactions, plays a role in neuromuscular transmission, and is involved in cardiovascular function.
## Primary Indications
* Treatment of hypomagnesemia.
* Prevention and treatment of seizures in preeclampsia and eclampsia.
* Management of status epilepticus refractory to first-line agents.
* Treatment of torsades de pointes.
* Adjunctive treatment for severe bronchospasm in asthma.
## Adult Dosing
* **Hypomagnesemia:**
* **Severe (serum Mg < 1.3 mg/dL):** 4-6 grams IV infused over 10-15 minutes, followed by 1-2 grams per hour infusion. Maintenance dose is typically 4-6 grams in 1 Liter of IV fluid over 24 hours.
* **Mild to moderate (serum Mg 1.3-1.7 mg/dL):** 2-4 grams IV infused over 10-15 minutes.
* **Preeclampsia/Eclampsia:**
* **Loading Dose:** 4-6 grams IV infused over 5-20 minutes.
* **Maintenance Dose:** 1-2 grams per hour IV infusion. Dosing may vary based on local protocol and patient response.
* **Torsades de Pointes:** 1-2 grams IV (diluted in 10 mL D5W) infused rapidly over 5-10 minutes. May repeat. Further infusion of 0.5-1 gram per hour may be administered.
* **Status Epilepticus (refractory):** 2-4 grams IV, often as an infusion. Specific protocols vary.
* **Severe Bronchospasm:** 1-2 grams IV infused over 15-20 minutes.
## Pediatric Dosing
Dosing for pediatric patients is highly variable and often based on weight and indication. Consultation with a pediatric specialist or adherence to institutional protocols is essential.
* **Hypomagnesemia:** Typical doses range from 25-50 mg/kg/dose IV, not to exceed 1-2 grams per dose, infused over 10-15 minutes. Maintenance infusions may be 20-30 mg/kg/hour.
* **Preeclampsia/Eclampsia:** Loading doses of 20-40 mg/kg IV (max 2 grams) followed by maintenance infusions of 10-20 mg/kg/hour (max 1 gram/hour).
* **Status Epilepticus (refractory):** 25-50 mg/kg IV infused over 10-30 minutes, maximum 2 grams.
## Dose Adjustments
* **Renal Impairment:** Magnesium is renally excreted. Use with caution in patients with renal impairment. Monitor serum magnesium levels closely. Reduced doses or extended infusion intervals may be necessary. In severe renal impairment, intravenous administration may be contraindicated.
## Contraindications
* Hypermagnesemia.
* Heart block.
* Myocardial infarction (in certain contexts).
* Hypocalcemia (use with caution, as it can exacerbate hypocalcemia).
* Anuria.
## Adverse Effects
* **Common:** Flushing, sweating, hypotension, somnolence, hyporeflexia, nausea, vomiting.
* **Serious:** Respiratory depression, cardiac arrest, hypermagnesemia (signs include absent deep tendon reflexes, hypotension, bradycardia, ECG changes, somnolence, confusion, muscle weakness, respiratory depression, cardiac arrest).
## Key Drug Interactions
* **Neuromuscular Blocking Agents:** Magnesium can potentiate neuromuscular blockade, increasing the risk of prolonged respiratory depression.
* **Calcium Channel Blockers:** Additive hypotensive effects.
* **Aminoglycosides:** May potentiate neuromuscular blockade.
* **Tetracyclines and Fluoroquinolones:** Magnesium can decrease the absorption of oral tetracyclines and fluoroquinolones; separate administration by at least 2-3 hours.
## Monitoring
* **Serum Magnesium Levels:** Especially with prolonged infusions or in renal impairment. Therapeutic levels for hypomagnesemia treatment are typically 2-4 mg/dL. For eclampsia, levels of 4-7 mg/dL are often targeted.
* **Renal Function:** Monitor BUN and creatinine.
* **Deep Tendon Reflexes:** Assess for hyporeflexia, an early sign of hypermagnesemia.
* **Respiratory Rate and Depth:** Monitor for respiratory depression.
* **Blood Pressure and Heart Rate:** Monitor for hypotension and bradycardia.
* **Urine Output:** Monitor for adequate renal function.
* **ECG:** Monitor for cardiac abnormalities.
## Clinical Pearls
* Magnesium sulfate is highly irritating to veins; always dilute for IV infusion and infuse slowly to minimize phlebitis.
* Rapid IV administration can cause hypotension and cardiac depression.
* Calcium salts (e.g., calcium gluconate) should be readily available for the treatment of magnesium toxicity.
* Parenteral magnesium is preferred for severe hypomagnesemia or when rapid correction is needed.
* Monitor closely for signs of hypermagnesemia, especially in patients with impaired renal function.
***
*This information is intended for healthcare professionals and does not substitute for clinical judgment. Always consult the most current prescribing information and institutional protocols before administering any medication.*
